Company Filing History:
Years Active: 2007
Title: Jan Schmollinger: Innovator in Tumor Antigen Research
Introduction
Jan Schmollinger is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of cancer research, particularly in the area of tumor antigens. His work focuses on the identification and utilization of tumor antigens for diagnostic and therapeutic purposes.
Latest Patents
Jan Schmollinger holds a patent for "Tumor antigens and uses thereof." This invention encompasses tumor antigens, tumor antigen-encoding nucleic acids, and antibodies specific for these tumor antigens. It also includes methods for identifying tumor antigens and the nucleic acids that encode them. Furthermore, the patent outlines methods for monitoring or diagnosing tumors in patients, testing patients for an increased likelihood of developing a tumor, and compositions for the treatment or prophylaxis against tumors. He has 1 patent to his name.
Career Highlights
Jan Schmollinger is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in oncology. His work has the potential to significantly impact cancer diagnosis and treatment, providing new avenues for patient care.
Collaborations
He has collaborated with notable colleagues in the field, including Glenn Dranoff and F. Stephen Hodi. These partnerships enhance the scope and impact of his research efforts.
Conclusion
Jan Schmollinger is a key figure in the development of innovative approaches to cancer treatment through his research on tumor antigens. His contributions are paving the way for advancements in cancer diagnostics and therapies.